Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Katapult Holdings (KPLT) Asset Writedowns and Impairment (2020 - 2024)

Historic Asset Writedowns and Impairment for Katapult Holdings (KPLT) over the last 5 years, with Q3 2024 value amounting to $5.5 million.

  • Katapult Holdings' Asset Writedowns and Impairment rose 1139.94% to $5.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $23.5 million, marking a year-over-year increase of 1137.07%. This contributed to the annual value of $22.0 million for FY2023, which is 2528.59% up from last year.
  • Latest data reveals that Katapult Holdings reported Asset Writedowns and Impairment of $5.5 million as of Q3 2024, which was up 1139.94% from $5.9 million recorded in Q2 2024.
  • Over the past 5 years, Katapult Holdings' Asset Writedowns and Impairment peaked at $9.4 million during Q4 2021, and registered a low of $3.2 million during Q1 2022.
  • In the last 5 years, Katapult Holdings' Asset Writedowns and Impairment had a median value of $5.4 million in 2023 and averaged $5.5 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first skyrocketed by 12084.6% in 2021, then plummeted by 4684.77% in 2022.
  • Quarter analysis of 5 years shows Katapult Holdings' Asset Writedowns and Impairment stood at $4.3 million in 2020, then surged by 120.85% to $9.4 million in 2021, then crashed by 40.24% to $5.6 million in 2022, then grew by 15.55% to $6.5 million in 2023, then dropped by 16.43% to $5.5 million in 2024.
  • Its Asset Writedowns and Impairment stands at $5.5 million for Q3 2024, versus $5.9 million for Q2 2024 and $5.6 million for Q1 2024.